Contemporary National Trends and Variations of Pelvic Lymph Node Dissection in Patients Undergoing Robot-Assisted Radical Prostatectomy.

[1]  R. Fathy,et al.  Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer , 2020, JAMA network open.

[2]  David C. Miller,et al.  Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium. , 2019, Urologic oncology.

[3]  A. D'Amico,et al.  Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  T. Guzzo,et al.  National trends and disparities of minimally invasive surgery for localized renal cancer, 2010 to 2015. , 2019, Urologic oncology.

[5]  Anojan Navaratnam,et al.  Updates in Urologic Robot Assisted Surgery , 2018, F1000Research.

[6]  F. Saad,et al.  Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis , 2018, International journal of urology : official journal of the Japanese Urological Association.

[7]  F. Saad,et al.  Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion , 2018, The Prostate.

[8]  Ronald C. Chen,et al.  Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options , 2018, The Journal of urology.

[9]  F. Montorsi,et al.  Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. , 2017, Urologic oncology.

[10]  Ronald C. Chen,et al.  Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options , 2017, The Journal of urology.

[11]  D. Boffa,et al.  Using the National Cancer Database for Outcomes Research: A Review , 2017, JAMA oncology.

[12]  M. Menon,et al.  Rate and Extent of Pelvic Lymph Node Dissection in the US Prostate Cancer Patients Treated With Radical Prostatectomy , 2017, Clinical genitourinary cancer.

[13]  M. Menon,et al.  Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer , 2017, Cancer.

[14]  Yubo Gao,et al.  Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base. , 2017, Cancer epidemiology.

[15]  E. Lerma,et al.  The Evolution of the Journal Club: From Osler to Twitter. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  F. Saad,et al.  Suboptimal use of pelvic lymph node dissection: Differences in guideline adherence between robot-assisted and open radical prostatectomy. , 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[17]  C. Gross,et al.  Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the National Cancer Database. , 2015, The Journal of urology.

[18]  F. Montorsi,et al.  The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  Stuart R Lipsitz,et al.  Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. , 2012, European urology.

[20]  V. Shavers,et al.  Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer , 2011, Cancer.

[21]  W. Lowrance,et al.  Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy , 2011, Cancer.

[22]  S. Lipsitz,et al.  Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men. , 2011, Urology.

[23]  John T. Wei,et al.  Racial/ethnic disparities in the treatment of localized/regional prostate cancer. , 2004, The Journal of urology.

[24]  B. D. Rowley.  AMA--Fellowship and Residency Electronic Interactive Database Access (AMA-FREIDA): a computerized residency selection tool. , 1988, JAMA.

[25]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[26]  M. Humphreys,et al.  Radical Prostatectomy Trends in the United States: 1998 to 2011. , 2016, Mayo Clinic proceedings.